| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |